Ventas (NYSE:VTR – Get Rating) had its price objective boosted by Morgan Stanley from $52.00 to $54.00 in a research note issued to investors on Wednesday, MarketBeat Ratings reports. They currently have an equal weight rating on the real estate investment trust’s stock.
Several other research firms have also recently weighed in on VTR. Credit Suisse Group started coverage on shares of Ventas in a research note on Wednesday, June 22nd. They issued an outperform rating and a $63.00 target price for the company. Capital One Financial began coverage on shares of Ventas in a research note on Friday, June 3rd. They set an overweight rating and a $63.00 price objective on the stock. Evercore ISI set a $59.00 target price on shares of Ventas in a research note on Monday, June 20th. Jefferies Financial Group raised Ventas from a hold rating to a buy rating and boosted their price target for the stock from $58.00 to $59.00 in a research report on Thursday, June 30th. Finally, Royal Bank of Canada raised their price objective on Ventas from $62.00 to $63.00 in a research report on Friday, May 20th. Three analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of Moderate Buy and an average target price of $61.13.
Ventas Stock Down 1.8 %
VTR stock opened at $47.35 on Wednesday. The company has a market cap of $18.93 billion, a price-to-earnings ratio of 947.19, a P/E/G ratio of 3.35 and a beta of 1.12. Ventas has a twelve month low of $45.44 and a twelve month high of $64.02. The business has a 50 day moving average price of $50.80 and a two-hundred day moving average price of $54.62. The company has a quick ratio of 0.60, a current ratio of 0.60 and a debt-to-equity ratio of 1.16.
Institutional Inflows and Outflows
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries – healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population.
- Get a free copy of the StockNews.com research report on Ventas (VTR)
- Could Snap Stock Rebound As Management Restructures?
- MarketBeat: Week in Review 8/29 – 9/2
- Hormel Looks Cheap At These Levels
- Lululemon Set To Soar Into September
- Could Nike Stock be Oversold, but Still Overvalued?
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.